Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Cipla
Queensland Health
Boehringer Ingelheim
Johnson and Johnson
Cantor Fitzgerald
Daiichi Sankyo
Mallinckrodt
Moodys
Harvard Business School

Generated: February 20, 2018

DrugPatentWatch Database Preview

METHIMAZOLE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for methimazole and what is the scope of methimazole patent protection?

Methimazole
is the generic ingredient in two branded drugs marketed by Eci Pharms Llc, Heritage Pharma, Mylan, Rising Pharms Inc, Sandoz, Sun Pharm Inds Inc, King Pharms, and King Pharms Llc, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for methimazole. Nineteen suppliers are listed for this compound.
Pharmacology for METHIMAZOLE
Medical Subject Heading (MeSH) Categories for METHIMAZOLE

US Patents and Regulatory Information for METHIMAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan METHIMAZOLE methimazole TABLET;ORAL 040350-001 Mar 29, 2000 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Heritage Pharma METHIMAZOLE methimazole TABLET;ORAL 040734-002 Dec 14, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz METHIMAZOLE methimazole TABLET;ORAL 040411-001 Mar 27, 2001 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Heritage Pharma METHIMAZOLE methimazole TABLET;ORAL 040734-001 Dec 14, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Eci Pharms Llc METHIMAZOLE methimazole TABLET;ORAL 040547-002 Feb 18, 2005 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
King Pharms TAPAZOLE methimazole TABLET;ORAL 007517-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan METHIMAZOLE methimazole TABLET;ORAL 040350-003 Jun 7, 2001 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
King Pharms TAPAZOLE methimazole TABLET;ORAL 007517-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Inc METHIMAZOLE methimazole TABLET;ORAL 040870-002 Sep 25, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
King Pharms Llc TAPAZOLE methimazole TABLET;ORAL 040320-002 Mar 31, 2000 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
Express Scripts
Queensland Health
Teva
Boehringer Ingelheim
UBS
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot